Erik Atkisson - 22 Sep 2021 Form 3 Insider Report for Eiger BioPharmaceuticals, Inc.

Role: GC & Chief Compliance Officer
Signature: /s/ Sriram Ryali, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 22 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 01 Oct 2021, 16:34:14 UTC
Next filing: 01 Oct 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney